Basket empty
Order line 0800 2800 486 or 0118 969 1402 Advice line 0845 017 0755
FREE Delivery on UK Orders From £24.99 - Same day shipping up to 3:45pm for most products
Categories
Adrenal Support
Anti-Ageing
Antioxidants
Beauty Products
Biocare Winter Essentials
Body fluid balance
Botanical Supplements
Candida
Children's Health
Cold & Immune Support
Colon health
Cowden Support Products
Detoxification
Digestive Enzymes
Energy Boosters
Eye Health
Fatty Acids
Food State Nutrients
General Health
Geopathic Stress
Glucosamine
Green Foods
Hair
Healthy Blood Sugar
Healthy Gut
Heart Health
Heavy Metals
Immune Health
Intestinal Gas balance
Joint Health
Kidney Health
Liposomal nutrients
Liver & Gall Bladder Health
Memory Maintenance
Men's Health
Microbiological Balancing
Miscellaneous
Mood Support
MSM
Oxygen Products
Pain & Inflammation
Pregnancy and Childbirth
Probiotics
Prostate Health
Respiratory Health
Sexual Health & Libido
Skin Care
Sleep and relaxation
Sports Performance
Sugar Cravings
Sugar Substitutes
Superfoods
Thyroid Health
Vein Support
Viral Management
Vitamins & Minerals
Weight Management
Women's Health
We are currently in the process of moving to another warehouse and orders placed this week may not be shipped until the week beginning February 26th

Oxy-Powder - Clinical Studies - Constipation

Buy Oxy-Powder - Click Here

This summary report has been extracted from the Original Phase I, II, and III active, controlled Clinical Studies on Oxy-Powder® (the full report is a 200 page pdf document).

We tested many components of Oxy-Powder® including acute toxicity, sub-chronic toxicity and anti-bacterial activity. We also tested the effectiveness of Oxy-Powder® for symptoms of chronic constipation, and IBS (Irritable Bowel Syndrome). For ease of reading, we summarized the results of each test.

According to the Rome II criteria for constipation, all patients in the study were suffering from constipation for 12 weeks (3 months) or more.

Summary of Oxy-Powder® Clinical Study for Chronic Constipation
  • 25 of 27 patients (92.6%) had straining during bowel movements on Day 0 as compared to Day 42 when only 2 (7.7%) patients had this symptom. A significant reduction in symptoms was achieved after administration of Oxy-Powder®.
  • 26 of 27 patients (96.3%) passed hard and lumpy stools on Day 0 where as on Day 42 it was reported only in two patients (7.7%). A significant reduction in symptoms was achieved after administration of Oxy-Powder®.
  • 25 of 27 patients (92.6%) had sensation of incomplete evacuation on Day 0 where as on Day 42 it was reported only in 5 (19.2%). A significant reduction in symptoms was achieved after administration of Oxy-Powder®.
  • 15 of 27 patients (55.6%) had sensation of anorectal blockage on Day 0 where as on Day 42 it was reported only in 1 (3.8%). A significant reduction in symptoms was achieved after administration of Oxy-Powder®.
  • 11 of 27 patients (40.7%) had to perform manual maneuvers to facilitate bowel movements on Day 0 where as by Day 21 it was reported that 0 patients had any further symptoms. A significant reduction in symptoms was achieved after administration of Oxy-Powder®.

One patient in the Oxy-Powder® administered group of 27 patients had severe diarrhea on the 2nd day of treatment. He could not carry out his usual activities and felt dehydrated; hence he was withdrawn from the study on 3rd day reducing the study population to 26 patients.

Routine stool examination done before and after the drug treatment showed no abnormality in all patients in this study.

Overall Efficacy - Oxy-Powder®


Overall Efficacy was independently judged by the Investigators and the Patients. It was graded as Excellent, Good, Fair, and Poor. The results were statistically analysed using Fisher's Exact Test.

Assessment- Investigators
Excellent 13 - 50.0 %
Good 12 - 46.2 %
Fair 1 - 3.8 %
Poor 0 - 0.0 %
Total 26 - 100.0 %
Assessment - Patients Drug Code Cross Tabulation
Excellent 12 - 46.2 %
Good 13 - 50.0 %
Fair 1 - 3.8 %
Poor 0 - 0.0 %
Total 26 - 100.0 %

Investigator Summary:
In the group of 26 patients, Investigator assessment was Excellent for 13 (50%), Good for 12 (46.2%), Fair for 1 (3.8 %), and Poor for none (0.0%). Results indicate Oxy-Powder® was effective in treating constipation and reducing the symptoms associated with constipation according to the Rome II Criteria for diagnosing chronic constipation.

Patient Summary:
In the group of 26 completed patients, the Patient assessment was Excellent for 12 (46.2%), Good for 13 (50%), Fair for 1 (3.8%), and Poor for none (0.0%). Results indicate Oxy-Powder® was effective in treating constipation and reducing the symptoms associated with constipation according to the Rome II Criteria for diagnosing chronic constipation.

Overall Efficacy was also judged as Complete Cure, Improvement, and Failure. Table 14 shows that in Group A (out of 26 patients), 11 patients (42.3%) had Complete Cure, 15 patients (57.7%) had Improvement, and there was no Failure.

Efficacy of Oxy-Powder® in Treating Chronic Constipation


Overall Efficacy was independently judged by the Investigators and the Patients. It was graded as Excellent, Good, Fair, and Poor. The results were statistically analysed using Fisher's Exact Test.

Change Observed Efficacy
Complete Cure 11 (42.3 %)
Improvement 15 (57.7 %)
Failure 0 - 0.0 %
Total 26 (100.0 %)
The final results indicated:

Complete cure: 42.3% patients treated with Oxy-Powder®.

Significant Improvement: 57.7% in patients treated with Oxy-Powder®.

Failure: 0% in patients treated with Oxy-Powder®.

Thus, efficacy of Oxy-Powder® in treating constipation was significant. This indicated Oxy-Powder® was efficacious in treating constipation.

Results Above Indicate Efficacy of Oxy-Powder® is Significant in Treating Patients of Constipation.

"The clinical trial has been conducted following Globally accepted Regulatory Guidelines and practices as follows":-

  • Human clinical trial was conducted following "Good Clinical Practices (GCP)" under supervision of an expert team following Helsinki's Declaration for protection of rights of the patients.The entire study was conducted based on globally accepted ICH 6E guidelines for determining Safety, Efficacy and Tolerability of Oxy-Powder® in Human subjects.
  • The Animal toxicity studies were conducted in an ISO certified laboratory following WHO GCP guidelines and as per OECD tests.
  • The capsules can be safely consumed by all vegetarians and non-vegetarians alike The ingredients, including the outer inactive cover (Kosher Shell) are Vegetarian. None of the non-vegetarian materials such as gelatin, egg product, meat or chicken products, sea food products, non-vegetarian oils and fats have been employed in the formulation or during processing.

Buy Oxy-Powder - Click Here